#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Progressive familial intrahepatic cholestasis Allogenic stem cell transplantation Malformation venous Acute myeloid leukaemia recurrent Plasma cell myeloma recurrent Cerebral amyloid angiopathy Cystic fibrosis respiratory infection suppression Glomerulonephritis Oesophageal adenocarcinoma Neurofibroma Gaucher's disease type III Angiosarcoma non-metastatic Myelin oligodendrocyte glycoprotein antibody-associated disease Immunoglobulin G4 related disease Metachromatic leukodystrophy More trials…

    Learn about Rare Diseases

    Paroxysmal nocturnal haemoglobinuria – Basic Information Choroid melanoma – Treatment Malignant fibrous histiocytoma – Treatment Leiomyosarcoma metastatic – Trials in Disease Andersen-Tawil syndrome – Treatment Splenic marginal zone lymphoma Glycogen storage disease type II Friedreich’s ataxia Glycogen storage disease type I Cystic fibrosis lung – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Caffeine Oxybuprocaine Bidridistrogene Xeboparvovec R-Azasetron Besilate IBANDRONIC ACID Loncastuximab Tesirine Ipratropium Bromide Sodium S-Lactate Solution Tramazoline Hydrochloride Brimonidine Tartrate Bupropion Hydrochloride Idecabtagene Vicleucel Immunglobulin Rifampicin GAXILOSE Inotuzumab Ozogamicin PARECOXIB Methotrexate Disodium Gs-5718-03 Acetylsalicylic Acid More therapies…

    Learn about Your Condition

    Osteochondrodysplasia Nicotine dependence Acoustic neuroma VEXAS syndrome Lyme disease Hereditary ataxia Wiskott-Aldrich syndrome Immune-mediated renal disorder Ocular lymphoma Rabies Vulvovaginal dryness Neuromuscular scoliosis Hyperadrenocorticism Glanzmann's disease Toxic nodular goitre More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Universitetssykehuset Nord-Norge HF

Universitetssykehuset Nord-Norge HF

P. O. Box 100, Tromsø, 9038, Norway

Want to learn more about this study or check if you can participate? Contact us.

  • Study of enzalutamide alone versus enzalutamide with radium-223 combination in patients with bone metastatic castration-resistant prostate cancer with mild or no symptoms

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Radium Ra 223 Dichloride
    • Enzalutamide
    Belgium Denmark France Ireland Italy Norway +2

  • Study on Dostarlimab, Carboplatin, and Paclitaxel for Patients with Recurrent or Advanced Endometrial Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Endometrial cancer stage III
    • Endometrial cancer stage IV
    Investigated Drugs:
    • Dostarlimab
    • Niraparib Tosilate Monohydrate
    Belgium Czechia Denmark Finland Germany Greece +7

  • Study on Rituximab and Drug Combination for Treating Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Vindesine Sulfate
    • Ifosfamide
    • Abiraterone Acetate
    Austria Czechia Denmark Finland Germany Norway +1

  • Study on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Upadacitinib
    Austria Belgium Croatia Czechia Estonia Finland +14

  • Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Lung disorder
    Investigated Drugs:
    • Baricitinib
    Austria Belgium Czechia France Germany Greece +8

  • Study of Oxaliplatin and Nivolumab for Patients with Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Metoclopramide Hydrochloride Anhydrous
    • Ondansetron Hydrochloride Dihydrate
    • Dexamethasone
    Norway

  • Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

    Not recruiting

    2 1
    Investigated Diseases:
    • Lung disorder
    Investigated Drugs:
    • Bemcentinib
    Belgium Czechia France Greece Ireland Italy +4

  • Study of Mosunetuzumab for Patients with Early Relapse of Follicular Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Mosunetuzumab
    Denmark Finland Norway Sweden

  • Study on the Effectiveness and Safety of HRO350 for Patients with Mild-to-Moderate Psoriasis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Pehero
    • Betamethasone Valerate
    Finland Germany Norway Poland

  • Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Prednisone
    • Secukinumab
    Belgium Czechia Denmark Finland France Germany +9
Previous Page
1 … 9 10 11 12 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!